How to understand clinical trial documents: patient guide

What is a patient information sheet?

A patient information sheet is a document given to you before you decide whether to join a clinical trial. It explains the trial's purpose, the treatments being tested, potential benefits and risks, and what your participation would involve^[1].

If you decide to consider taking part in a trial, you should be given full information covering the purpose of the trial, the potential benefits and risks, and all relevant details before being asked to make a decision^[2]. The research team is expected to walk you through this information rather than simply hand you paperwork^[1]. This distinction matters, as a patient information sheet is meant to be read at your own pace^[2].

What is the informed consent form, and why is it different from a contract?

The informed consent form is a detailed description of the trial's goals and processes, including any risks, potential benefits, experimental procedures and alternatives to taking part. It also states how long the trial may last, follow-up requirements, and any costs or compensation involved^[1].

The document is not a contract between you and the healthcare or research team. It confirms that your participation is voluntary^[1].

Ensuring that you fully understand and feel comfortable with the decision to participate is described as crucial to the entire research process. If the document is written in medical or legal language you do not follow, you can always ask the researcher or the research team for clarification. Understanding, in this context, is not a formality; it is treated as a condition that must be genuinely met, not merely a box that gets ticked once a signature appears on the page^[2].

What happens before a trial starts, and why does it matter for your consent?

Before any participant is approached, a trial goes through several stages that shape what the consent form will say^[1]. Understanding these stages helps explain why certain information appears in the document you are given.

• Preclinical tests — laboratory tests or studies in animals evaluate a new therapy such as a drug, a combination of drugs, or a medical device before any human trial is designed^[1].
• Clinical trial protocol — if preclinical tests show potential, researchers develop an action plan describing the trial's purpose, the treatments under evaluation, and the trial endpoints, meaning what researchers expect to measure^[1].
• Institutional review and approval — the ethics committee or institutional review board for each participating institution reviews the protocol, focusing on participant safety and rights^[1].
• Recruitment and informed consent — only once approval is granted can researchers begin recruiting participants and holding the informed consent conversation^[1].

Each trial's documentation is reviewed by multiple experts. This review is designed to ensure the trial is as safe as possible for participants, and a trial plan is not approved if the potential risk to participants is judged too great. This scrutiny happens before you are ever approached^[2].

How do you know if you are eligible to take part?

Each clinical trial has inclusion and exclusion criteria describing who can, or cannot, participate, such as a certain age, sex, or health condition. These requirements exist to keep each trial as safe as possible for the people taking part^[2].

As part of screening, a research team may look at your medical history and ask you questions to see whether you are suitable for the study before it starts^[3]. Clinical trials are not limited to people with serious illness: they also cover improving quality of life, disease prevention, and earlier diagnosis, and both adults and children can take part in dedicated paediatric trials. When you read the eligibility section of a document, it can help to remember that these criteria are not arbitrary gatekeeping. They exist so that people who might be harmed by a particular intervention are not exposed to unnecessary risk^[2].

What do "randomised", "blind" and "placebo" mean in a consent document?

The consent document will state whether the trial is randomised. This means that the treatment group you join is decided by chance, a bit like flipping a coin, rather than chosen by you or your doctor. The chances are not always equal: in some trials, more participants receive the new treatment than the comparison treatment, and the document should tell you what your chances are. Not everyone in a randomised trial receives the experimental treatment. This is important to know if you are joining a trial hoping to receive a new treatment, because you may instead be assigned to a comparison group[1].

The document will also say whether the trial is blind (sometimes called "masked"). In a single-blind trial, you do not know which group you are in. In a double-blind trial, neither you nor the doctors running the trial know. Blinding helps make sure that expectations do not influence the results. It does not put your safety at risk: if you need urgent medical care, the research team can quickly find out which treatment you are receiving[1].

Some trials compare a new treatment with a placebo. A placebo looks like the treatment being tested but contains no active substance. In many trials, the placebo is given alongside your usual treatment rather than instead of it, so everyone still receives standard care. Ethical rules generally do not allow a placebo to replace an effective treatment if going without it would put you at risk. If the consent document mentions a placebo, ask the research team whether you will continue your usual treatment while taking part[1].

Is your study a clinical trial or an observational study?

Clinical research falls into two broad categories, and knowing which one applies to you helps you read the consent document correctly. Interventional studies, also called clinical trials, test the effectiveness and safety of medicines, procedures or medical devices. Observational studies collect and analyse information about people's health, such as medical records or biological samples, without changing their treatment. If you are joining an observational study, you will not be assigned to a new medicine or procedure, so terms such as "randomised" or "placebo" will not appear in your documents. Knowing the type of study helps you understand what taking part will involve for you[4].

How should you approach medical and legal language you do not understand?

The informed consent form is a difficult document to understand because it is written in medical and legal language^[2]. Details in a clinical trial may be technical and confusing, so the recommended approach is to take your time and ask as many questions as you want before signing anything. A practical habit is worth adopting: read the document once in full without pausing on any single unfamiliar term, then go back through it a second time. Mark every sentence or phrase you would not be able to explain to someone else in your own words, as those are precisely the points worth raising with the research team^[1].

How is your personal and health data used once you join a trial?

When you agree to take part in a study, the research team may look at your medical history and ask you questions to check suitability, and during the study you may have blood tests, other health checks, or complete questionnaires. The research team records this information in special forms and combines it with information from every other participant; this combined information is called research data^[3].

Data about your health that identifies you, for example being linked to your name or NHS number, is called confidential patient data, and special rules apply to keep it private, safe and secure. All research should only use the data about you that is essential to carry out the research, and you can ask which parts of your health records will be looked at^[3].

In many studies, most of the research team will not need to know your name; someone removes your name from the research data and replaces it with a code number, a process known as pseudonymisation. For example, a blood test sample might be labelled with your code number instead of your name, and it can later be matched to your other data through that code^[5].

Term used in documents	What it means
Patient data / patient information	Any information recorded about your health problems, tests and treatment when you attend a GP, hospital or other care provider[5].
Confidential / identifiable patient data	Health data linked to information that can show who you are, such as your name or NHS number[3].
Research data	Information the research team records about you during the study, combined with the data of every other participant[3].
Coded / pseudonymised data	Your name is replaced with a code number so most of the research team cannot identify you directly[5].

Who reviews and oversees a clinical trial before and during your participation?

The ethics committee or institutional review board for any hospital participating in a trial reviews the protocol, with its focus on participant safety and rights^[1]. Experts also monitor the trial while it is running, and doctors monitor participants' health throughout^[2].

Sponsors of research, including companies developing new medicines or devices, NHS organisations, universities or medical research charities, act as the data controller because they decide what information is collected for the study and how it is used^[3]. Pharmaceutical companies bear the cost of research into new therapies, which is checked for both efficacy and safety before it reaches patients^[2].

In the United States, clinical trials require approval from the Food and Drug Administration (FDA) before researchers can start the trial, alongside the institutional review board's assessment^[1].

Will taking part in a trial cost you money, and what if something goes wrong?

Participation in a clinical trial is usually free of charge, although depending on the specific trial and location there may be additional costs such as travel, parking or hotel accommodation. Many trials offer to reimburse participants for these additional expenses^[2].

As part of participant protection, a Compensation Fund exists to compensate clinical trial participants and their next of kin for any harm suffered as a result of participating in a trial^[2]. The consent document itself will also list information about costs and compensation specific to that trial^[1]. Arrangements for reimbursement and compensation can vary considerably between trials, so it is worth reading this section closely rather than assuming it mirrors what a friend or relative experienced in a different study^[2].

Can you withdraw after signing the consent form, and what about your medical information afterwards?

Every participant in a clinical trial has the right to withdraw from it at any time without repercussions^[2]. Signing the informed consent form is not a binding contract, and it confirms only that your participation is voluntary^[1].

As a participant, you also have the right to obtain information from the doctor about your condition at any time during the trial and to see your medical records^[2]. You can leave a trial at any time, and your well-being remains the clinical trial team's top priority throughout your participation^[1].

When should you ask the research team or seek outside advice before signing?

You should ask for clarification whenever a section of the patient information sheet or consent form is unclear, since ensuring full understanding is described as crucial to the entire research process^[2]. It is also worth asking a few specific questions. What happens if the trial is randomised and you do not receive the experimental treatment? What follow-up requirements, costs or compensation apply? What data about you will be recorded, and who can see it?^[1]

If your doctor has not mentioned a clinical trial you might be eligible for, this does not mean none exists for your condition, since a doctor may not know about every available trial. Patient advocacy groups, non-governmental organisations, patient organisations and dedicated clinical trial search engines can help you find studies related to your condition^[2].

Summary

A patient information sheet and an informed consent form together are designed to give you everything you need to decide, freely and with understanding, whether to join a clinical trial. They describe the trial's purpose, procedures, risks, benefits, costs, data use and your right to withdraw at any time, and none of this removes your ongoing right to ask questions or see your own medical records^[1].

If any wording remains unclear after reading these documents, the appropriate next step is to ask the researcher or research team directly, rather than to sign without understanding^[2]. Taking your time over this decision is a normal and expected part of the consent process, not an obstacle to it^[1].

1. [1] Cleveland Clinic. Clinical trial (clinical study) (accessed 2 June 2026) — https://my.clevelandclinic.org/health/articles/clinical-trial
2. [2] Agencja Badań Medycznych (pacjentwbadaniach.abm.gov.pl). Myths & facts about clinical trials - fact sheet (accessed 2 June 2026) — https://pacjentwbadaniach.abm.gov.pl/download/3/9003/Mythsandfactsaboutclinicaltrails-factsheet.pdf
3. [3] Health Research Authority. Patient data and research leaflet (accessed 2 June 2026) — https://www.hra.nhs.uk/planning-and-improving-research/policies-standards-legislation/data-protection-and-information-governance/gdpr-guidance/templates/template-wording-for-generic-information-document/
4. [4] Pulse, a blog powered by StudyPages. The ultimate guide to understanding clinical trials and research in healthcare (accessed 2 June 2026) — https://studypages.com/blog/a-comprehensive-guide-to-all-you-need-to-know-about-clinical-trials-and-research-in-healthcare/
5. [5] NCA Research (Research & Innovation). Information on the use of patient data in clinical research (accessed 2 June 2026) — https://www.ncaresearch.org.uk/news/information-on-the-use-of-patient-data-in-clinical-research/